亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study

曲前列环素 医学 析因分析 肺活量 内科学 心脏病学 肺动脉高压 间质性肺病 重症监护医学 事后 肺 扩散能力 肺功能
作者
Steven D. Nathan,Aaron B. Waxman,Sudarshan Rajagopal,Amy Hajari Case,Shilpa Johri,Hilary M. DuBrock,David J. De La Zerda,Sandeep Sahay,Christopher S. King,Lana Melendres‐Groves,Peter Smith,Eric Shen,Lisa Edwards,Andrew C. Nelsen,Victor F. Tapson
出处
期刊:The Lancet Respiratory Medicine [Elsevier BV]
卷期号:9 (11): 1266-1274 被引量:136
标识
DOI:10.1016/s2213-2600(21)00165-x
摘要

INCREASE was a randomised, placebo-controlled, phase 3 trial that evaluated inhaled treprostinil in patients with interstitial lung disease (ILD) and associated pulmonary hypertension. Treprostinil improved exercise capacity from baseline to week 16, assessed with the use of a 6-min walk test, compared with placebo. Improvements in forced vital capacity (FVC) were also reported. The aim of this post-hoc analysis was to further characterise the effects of inhaled treprostinil on FVC in the overall study population and in various subgroups of interest.In this post-hoc analysis, we evaluated FVC changes in the overall study population and in various subgroups defined by cause of disease or baseline clinical parameters. The study population included patients aged 18 years and older who had a diagnosis of ILD based on evidence of diffuse parenchymal lung disease on chest CT done within 6 months before random assignment (not centrally adjudicated). All analyses were done on the intention-to-treat population, defined as individuals who were randomly assigned and received at least one dose of study drug. The INCREASE study is registered with ClinicalTrials.gov, NCT02630316.Between Feb 3, 2017, and Aug 30, 2019, 326 patients were enrolled in the INCREASE trial. Inhaled treprostinil was associated with a placebo-corrected least squares mean improvement in FVC of 28·5 mL (SE 30·1; 95% CI -30·8 to 87·7; p=0·35) at week 8 and 44·4 mL (35·4; -25·2 to 114·0; p=0·21) at week 16, with associated percentage of predicted FVC improvements of 1·8% (0·7; 0·4 to 3·2; p=0·014) and 1·8% (0·8; 0·2 to 3·4; p=0·028). Subgroup analysis of patients with idiopathic interstitial pneumonia showed FVC differences of 46·5 mL (SE 39·9; 95% CI -32·5 to 125·5; p=0·25) at week 8 and 108·2 mL (46·9; 15·3 to 201·1; p=0·023) at week 16. Analysis of patients with idiopathic pulmonary fibrosis showed FVC differences of 84·5 mL (52·7; -20·4 to 189·5; p=0·11) at week 8 and 168·5 mL (64·5; 40·1 to 297·0; p=0·011) at week 16. The most frequent adverse events included cough, headache, dyspnoea, dizziness, nausea, fatigue, and diarrhoea.In patients with ILD and associated pulmonary hypertension, inhaled treprostinil was associated with improvements in FVC versus placebo at 16 weeks. This difference was most evident in patients with idiopathic interstitial pneumonia, particularly idiopathic pulmonary fibrosis. Inhaled treprostinil appears to be a promising therapy for idiopathic pulmonary fibrosis that warrants further investigation in a prospective, randomised, placebo-controlled study.United Therapeutics Corporation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
12秒前
自然的妙梦完成签到,获得积分10
55秒前
yc关闭了yc的文献求助
57秒前
1分钟前
vitamin完成签到 ,获得积分0
1分钟前
Orange的应助被荷兰香猪采纳,获得10
1分钟前
1分钟前
荷兰香猪发布了新的文献求助10
1分钟前
漂亮的半兰完成签到,获得积分10
1分钟前
2分钟前
Heart_of_Stone完成签到 ,获得积分10
2分钟前
2分钟前
友好大树发布了新的文献求助10
2分钟前
gd完成签到 ,获得积分10
2分钟前
科研通AI65的应助被amiee采纳,获得10
3分钟前
Akim的应助被盼盼采纳,获得10
3分钟前
3分钟前
3分钟前
3分钟前
科目三的应助被荷兰香猪采纳,获得10
3分钟前
3分钟前
3分钟前
不忘初鑫完成签到 ,获得积分10
3分钟前
amiee发布了新的文献求助10
3分钟前
荷兰香猪发布了新的文献求助10
3分钟前
顺心安雁完成签到,获得积分10
3分钟前
汉堡包的应助被whc采纳,获得10
3分钟前
3分钟前
科研通AI6.3的应助被聪慧亦凝采纳,获得10
3分钟前
whc发布了新的文献求助10
3分钟前
4分钟前
李爱国的应助被初景采纳,获得10
4分钟前
聪慧亦凝发布了新的文献求助10
4分钟前
动听的诗翠完成签到,获得积分10
4分钟前
虚拟的清炎完成签到 ,获得积分10
4分钟前
4分钟前
初景发布了新的文献求助10
4分钟前
充电宝的应助被荷兰香猪采纳,获得10
4分钟前
香蕉觅云的应助被蔓越莓奶酥采纳,获得30
4分钟前
沉默的樱完成签到,获得积分10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190159
求助须知:如何正确求助?哪些是违规求助? 9577257
关于积分的说明 21852297
捐赠科研通 7788567
什么是DOI,文献DOI怎么找? 3436279
关于科研通互助平台的介绍 2560058
邀请新用户注册赠送积分活动 2482880